South Dakota Investment Council Makes New $2.75 Million Investment in Waters Corporation $WAT

South Dakota Investment Council bought a new stake in Waters Corporation (NYSE:WAT – Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 6,254 shares of the medical instruments supplier’s stock, valued at approximately $2,748,000.

A number of other large investors also recently modified their holdings of WAT. Ashton Thomas Securities LLC raised its holdings in Waters by 3.5% in the third quarter. Ashton Thomas Securities LLC now owns 704 shares of the medical instruments supplier’s stock valued at $309,000 after buying an additional 24 shares during the period. Caitlin John LLC raised its position in Waters by 43.9% in the second quarter. Caitlin John LLC now owns 82 shares of the medical instruments supplier’s stock valued at $31,000 after purchasing an additional 25 shares during the period. Park Avenue Securities LLC lifted its stake in shares of Waters by 2.8% during the third quarter. Park Avenue Securities LLC now owns 910 shares of the medical instruments supplier’s stock worth $400,000 after purchasing an additional 25 shares in the last quarter. Kingswood Wealth Advisors LLC boosted its position in shares of Waters by 3.7% in the third quarter. Kingswood Wealth Advisors LLC now owns 786 shares of the medical instruments supplier’s stock worth $345,000 after buying an additional 28 shares during the period. Finally, Kestra Investment Management LLC boosted its holdings in Waters by 4.0% in the 3rd quarter. Kestra Investment Management LLC now owns 783 shares of the medical instruments supplier’s stock worth $344,000 after acquiring an additional 30 shares during the period. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. The Goldman Sachs Group upped their target price on shares of Waters from $465.00 to $515.00 and gave the company a “buy” rating in a research note on Monday, September 21st. Citigroup increased their price target on Waters from $470.00 to $536.00 and gave the company a “buy” rating in a report on Wednesday, November 4th. Stifel Nicolaus set a $470.00 target price on Waters in a research note on Wednesday, November 4th. JPMorgan Chase & Co. upped their price target on shares of Waters from $435.00 to $470.00 and gave the company a “neutral” rating in a report on Wednesday, November 4th. Finally, Sanford C. Bernstein reissued an “outperform” rating and set a $535.00 price objective on shares of Waters in a report on Wednesday, November 4th. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, Waters currently has an average rating of “Moderate Buy” and an average price target of $475.48.

Read Our Latest Stock Report on Waters

Waters Stock Down 1.9%

WAT stock opened at $457.14 on Friday. Waters Corporation has a 1-year low of $282.77 and a 1-year high of $483.33. The firm has a fifty day moving average price of $444.54 and a two-hundred day moving average price of $375.70. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.89 and a quick ratio of 1.28. The firm has a market cap of $44.93 billion, a price-to-earnings ratio of 196.20, a PEG ratio of 2.65 and a beta of 1.16.

Waters (NYSE:WAT – Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The medical instruments supplier reported $4.10 earnings per share for the quarter, topping the consensus estimate of $4.00 by $0.10. Waters had a net margin of 1.75% and a return on equity of 9.91%. The firm had revenue of $1.77 billion for the quarter, compared to analyst estimates of $1.75 billion. During the same quarter in the prior year, the business earned $3.40 earnings per share. Waters’s quarterly revenue was up 120.9% on a year-over-year basis. Research analysts predict that Waters Corporation will post 14.65 EPS for the current year.

Waters Company Profile

(Free Report)

Waters Corporation develops and supplies analytical instruments, software, and consumables used to identify, measure, and characterize chemical and biological materials. Its products include liquid chromatography and mass spectrometry systems, which help customers analyze complex samples. The company serves pharmaceutical and biotechnology businesses, academic and government laboratories, and customers in fields such as food, environmental testing, and materials science. Waters operates internationally, with customers and operations across multiple regions.

See Also

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT – Free Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.